2342 — Trans Genic Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsBalancedMicro CapNeutral

Annual cashflow statement for Trans Genic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	203	-250	695	2,768	-332
Depreciation
Amortisation
Non-Cash Items	68.5	337	158	-680	166
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-314	-339	264	-526	-1,448
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	148	-21	1,369	1,789	-1,430
Capital Expenditures	-320	-257	-146	-532	-306
Purchase of Fixed Assets
Other Investing Cash Flow Items	-514	-61.9	194	1,514	90.3
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-835	-319	48.4	982	-216
Financing Cash Flow Items	-57.8	-61.3	-146	-73.9	-16.1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	194	667	10	-1,183	485
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-495	326	1,427	1,588	-1,159